Sensitizing antigen-specific CD8+ T cells for accelerated suicide causes immune incompetence

Area of Science:

• Immunology
• Cellular Biology
• Virology

Background:

• Activation-induced cell death (AICD) of T cells is vital for peripheral tolerance and immune homeostasis.
• Defective AICD contributes to autoimmune diseases, suggesting therapeutic potential in enhancing T cell apoptosis.
• Bisindolylmaleimide VIII (Bis VIII), a PKC inhibitor, sensitizes T cells to death receptor-induced apoptosis.

Purpose of the Study:

• To investigate the functional consequences of enhanced T cell apoptosis on protective immune responses.
• To determine the mechanism by which Bis VIII sensitizes T cells to AICD.
• To evaluate the impact of Bis VIII administration on antiviral immunity in vivo.

Main Methods:

• In vitro and in vivo sensitization of CD8+ T cells to AICD using Bis VIII.
• Analysis of cellular FLICE-like inhibitory protein (cFLIP(L)) expression.
• Assessment of CD8+ T cell depletion, cytotoxicity, and viral clearance during lymphocytic choriomeningitis virus (LCMV) infection.

Main Results:

• Bis VIII effectively sensitizes CD8+ T cells to AICD both in vitro and in vivo.
• Bis VIII downregulates the antiapoptotic protein cFLIP(L), mediating its sensitizing effect.
• Administration of Bis VIII during LCMV infection leads to CD8+ T cell depletion, impaired cytotoxicity, and reduced viral clearance.

Conclusions:

• Resistance to death receptor-induced apoptosis is essential for mounting an effective protective immune response.
• Bis VIII enhances T cell apoptosis by downregulating cFLIP(L), but this can compromise antiviral immunity.
• Therapeutic application of Bis VIII requires careful control to prevent immune incompetence and susceptibility to infections.